Cite
Seidensticker M, Fabritius MP, Beller J, et al. Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization. Cancers (Basel). 2021;13(9)doi: 10.3390/cancers13091992.
Seidensticker, M., Fabritius, M. P., Beller, J., Seidensticker, R., Todica, A., Ilhan, H., Pech, M., Heinze, C., Powerski, M., Damm, R., Weiss, A., Rueckel, J., Omari, J., Amthauer, H., & Ricke, J. (2021). Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization. Cancers, 13(9), . https://doi.org/10.3390/cancers13091992
Seidensticker, Max, et al. "Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization." Cancers vol. 13,9 (2021). doi: https://doi.org/10.3390/cancers13091992
Seidensticker M, Fabritius MP, Beller J, Seidensticker R, Todica A, Ilhan H, Pech M, Heinze C, Powerski M, Damm R, Weiss A, Rueckel J, Omari J, Amthauer H, Ricke J. Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization. Cancers (Basel). 2021 Apr 21;13(9). doi: 10.3390/cancers13091992. PMID: 33919073; PMCID: PMC8122451.
Copy
Download .nbib